CNR Institutional Research Information System

CIMMINO, AMELIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.071
NA - Nord America 676
EU - Europa 362
SA - Sud America 188
AF - Africa 18
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 642
SG - Singapore 436
CN - Cina 250
BR - Brasile 162
IT - Italia 137
VN - Vietnam 110
HK - Hong Kong 109
FR - Francia 56
KR - Corea 50
NL - Olanda 33
DE - Germania 31
GB - Regno Unito 26
IN - India 23
FI - Finlandia 20
BD - Bangladesh 16
CA - Canada 16
JP - Giappone 16
ID - Indonesia 13
AR - Argentina 10
ES - Italia 9
MX - Messico 9
ZA - Sudafrica 8
AT - Austria 7
IQ - Iraq 7
RU - Federazione Russa 7
SA - Arabia Saudita 6
EC - Ecuador 5
PK - Pakistan 5
PL - Polonia 5
TR - Turchia 5
AL - Albania 4
PT - Portogallo 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
AZ - Azerbaigian 3
CO - Colombia 3
DZ - Algeria 3
HU - Ungheria 3
JO - Giordania 3
MA - Marocco 3
UA - Ucraina 3
UY - Uruguay 3
CH - Svizzera 2
EE - Estonia 2
GT - Guatemala 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
LK - Sri Lanka 2
OM - Oman 2
RS - Serbia 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IE - Irlanda 1
IR - Iran 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.319
Salva come PNG Salva come JPEG
Città #
Singapore 261
Santa Clara 125
Hong Kong 107
Hefei 90
Dallas 88
San Jose 63
Ashburn 54
Seoul 50
Ho Chi Minh City 49
Los Angeles 45
Beijing 44
Lauterbourg 40
Naples 31
Hanoi 19
São Paulo 19
New York 14
Tokyo 14
Frankfurt am Main 12
Helsinki 11
Orem 11
Lappeenranta 9
Nuremberg 9
Buffalo 8
Denver 8
Pisa 8
Rome 8
Poplar 7
Afragola 6
Genoa 6
Rio de Janeiro 6
Amsterdam 5
Baghdad 5
Bengaluru 5
Da Nang 5
Haiphong 5
Johannesburg 5
London 5
Marigliano 5
Warsaw 5
Ardea 4
Belo Horizonte 4
Bologna 4
Boston 4
Brooklyn 4
Chicago 4
Düsseldorf 4
Mexico City 4
Montreal 4
Palermo 4
Riyadh 4
Stockholm 4
Tirana 4
Vienna 4
Amman 3
Avellino 3
Baku 3
Chennai 3
Concord 3
Council Bluffs 3
Curitiba 3
Falkenstein 3
Guarulhos 3
Ha Long 3
Indore 3
Jakarta 3
Lahore 3
Mumbai 3
Phoenix 3
Thái Bình 3
Alfenas 2
Alliance 2
Ankara 2
Aracaju 2
Austin 2
Bauru 2
Belgrade 2
Betim 2
Bishkek 2
Biên Hòa 2
Boardman 2
Can Tho 2
Cape Coral 2
Cascina 2
Chandigarh 2
Colombo 2
Crawfordville 2
Eunápolis 2
Fairburn 2
Fort Mill 2
Franklin 2
Guangzhou 2
Guatemala City 2
Guayaquil 2
Henderson 2
Hyderabad 2
Ivry-sur-Seine 2
Lviv 2
Maceió 2
Madrid 2
Marrakesh 2
Totale 1.433
Salva come PNG Salva come JPEG
Nome #
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 181
Peri-prostatic adipocyte-released tgfβ enhances prostate cancer cell motility by upregulation of connective tissue growth factor 147
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis 89
New Challenges in Bladder Cancer Diagnosis: How Biosensing Tools Can Lead to Population Screening Opportunities 88
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives 87
Un metodo in vitro per il rilevamento del cancro della vescica dalle urine 75
Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis 69
aV-Integrin-Dependent Inhibition of Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry by the uPAcyclin Decapeptide 66
Subcellular localization of UC.8+ as a prognostic biomarker in bladder cancer tissue 65
Determination of picomolar concentrations of paraoxon in human urine by fluorescence-based enzymatic assay 63
Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic 62
The Fra-1/AP-1 Oncoprotein: From the "Undruggable" Transcription Factor to Therapeutic Targeting 59
L-Proline Induces a Mesenchymal-like Invasive Program in Embryonic Stem Cells by Remodeling H3K9 and H3K36 Methylation 59
Tumorigenesis-Related Long Noncoding RNAs and Their Targeting as Therapeutic Approach in Cancer 59
Emerging role of oncogenic long noncoding RNA as cancer biomarkers 56
An Ultraconserved Element Containing lncRNA Preserves Transcriptional Dynamics and Maintains ESC Self-Renewal. 54
A new biomarker panel of ultraconserved long non-coding RNAs for bladder cancer prognosis by a machine learning based methodology 52
Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers 50
Effects of long non-coding RNAs on androgen signaling pathways in genitourinary malignancies 50
Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer 49
Molecular characterization of G6PD deficiency in Southern Italy: heterogeneity correlation genotype-phenotype description of a new variant (G6PD Neapolis). 49
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 42
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation 41
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation 40
Circulating tumor cells in bladder cancer: A new horizon of liquid biopsy for precision medicine 40
Epigenetic alteration of microRNAs in DNMT3B-mutated patients of ICF syndrome 39
L-Proline remodels non-coding RNA gene expression profiles in Embryonic Stem Cells 39
L-Proline controls mouse ESC metastability modulating the epigenetic signature across the genome 39
Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. 37
The ZFP57 imprinting factor and epigenetic control: further clues stemming from expression profiling, ChIP seq and in vitro-induced differentiation 37
1)"Chemical modifications in the seed region of miRNA 221/222 increase silencing performances in GIST cancer" 36
L-Proline controls mouse ESC metastability modulating the epigenetic signature 35
Binding studies of antimicrobial peptides to Escherichia coli cells 35
Molecole di RNA isolate e loro usi 34
Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine. 31
Circular RNAs: An emerging type of non-coding RNA and their potential implications in bladder cancer 29
Direct detection of organophosphate compounds in water by a fluorescence-based biosensing device 27
New cross-talk layer between ultraconserved non-coding RNAs, microRNAs and polycomb protein YY1 in bladder cancer 27
The role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer. 27
Oligonucleotide Analogues as Modulators of the Expression and Function of Noncoding RNAs (ncRNAs): Emerging Therapeutics Applications. 26
microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics 26
Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS) 26
Chemical modifications in the seed region of miRNAs 221/222 increase the silencing performances in gastrointestinal stromal tumor cells. 26
Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia 23
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers 23
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs (vol 8, 2017) 20
Modulation of the pentose phosphate pathway induces endodermal differentiation in embryonic stem cells. 18
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance. 18
null 4
Totale 2.374
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.312
article - articoli 7.092
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 206
Totale 15.610
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202414 0 0 0 0 0 0 0 0 0 0 11 3
2024/2025772 3 2 63 24 117 67 26 40 33 57 178 162
2025/20261.524 59 96 210 270 282 50 208 64 81 116 47 41
2026/202764 64 0 0 0 0 0 0 0 0 0 0 0
Totale 2.374